Marin F - Search Results

1

The wearable cardioverter-defibrillator: current technology and evolving indications.

Reek S, Burri H, Roberts PR, Perings C, Epstein AE, Klein HU; EHRA Scientific Documents Committee (as external reviewers):; Lip G, Gorenek B, Sticherling C, Fauchier L, Goette A, Jung W, Vos MA, Brignole M, Elsner C, Dan GA, Marin F, Boriani G, Lane D, Blomström-Lundqvist C, Savelieva I. Reek S, et al. Among authors: marin f. Europace. 2017 Mar 1;19(3):335-345. doi: 10.1093/europace/euw180. Europace. 2017. PMID: 27702851 Review.

2

Fibrinolytic function and atrial fibrillation.

Marín F, Roldán V, Lip GY. Marín F, et al. Thromb Res. 2003 Mar 15;109(5-6):233-40. doi: 10.1016/s0049-3848(03)00259-7. Thromb Res. 2003. PMID: 12818244 Review.

3

Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation.

Climent V, Marín F, Mainar L, Roldán V, García A, Martínez JG, Lip GY. Climent V, et al. Among authors: marin f. Int J Cardiol. 2009 Feb 20;132(2):227-32. doi: 10.1016/j.ijcard.2007.11.044. Epub 2008 Jan 30. Int J Cardiol. 2009. PMID: 18234374

4

Mortality in patients with atrial fibrillation: improving or not?

Taggar JS, Marín F, Lip GY. Taggar JS, et al. Among authors: marin f. Europace. 2008 Apr;10(4):389-90. doi: 10.1093/europace/eun054. Epub 2008 Mar 8. Europace. 2008. PMID: 18326851 No abstract available.

5

Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.

Cambronero F, Marín F, Roldán V, Hernández-Romero D, Valdés M, Lip GY. Cambronero F, et al. Among authors: marin f. Eur Heart J. 2009 Jan;30(2):139-51. doi: 10.1093/eurheartj/ehn538. Epub 2009 Jan 9. Eur Heart J. 2009. PMID: 19136482 Review.

6

Antithrombotic therapy use after percutaneous coronary intervention and stent implantation in patients taking chronic oral anticoagulation.

Ruiz-Nodar JM, Marín F, Lip GY. Ruiz-Nodar JM, et al. Among authors: marin f. JACC Cardiovasc Interv. 2008 Jun;1(3):329; author reply 330-1. doi: 10.1016/j.jcin.2008.03.016. JACC Cardiovasc Interv. 2008. PMID: 19463322 Free article. No abstract available.

7

Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence.

Marín F, Kirchhof P, Lip GY. Marín F, et al. Europace. 2009 Jul;11(7):842-3. doi: 10.1093/europace/eup161. Europace. 2009. PMID: 19546184 No abstract available.

8

Thrombogenesis in lone atrial fibrillation: a role for soluble P-selectin?

Montoro-García S, Marín F, Lip GY. Montoro-García S, et al. Among authors: marin f. Europace. 2011 Jan;13(1):3-4. doi: 10.1093/europace/euq376. Epub 2010 Oct 25. Europace. 2011. PMID: 20974759 No abstract available.

9

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.

Lip GY, Andreotti F, Fauchier L, Huber K, Hylek E, Knight E, Lane DA, Levi M, Marin F, Palareti G, Kirchhof P; Document reviewers:; Collet JP, Rubboli A, Poli D, Camm J. Lip GY, et al. Among authors: marin f. Europace. 2011 May;13(5):723-46. doi: 10.1093/europace/eur126. Europace. 2011. PMID: 21515596

10

The improved but unfinished business of stroke risk stratification in atrial fibrillation.

Banerjee A, Marín F, Lip GY. Banerjee A, et al. Among authors: marin f. Rev Esp Cardiol. 2011 Aug;64(8):639-41. doi: 10.1016/j.recesp.2011.04.005. Epub 2011 Jun 17. Rev Esp Cardiol. 2011. PMID: 21684058 Free article. English, Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,128 results

Search Page